Tazobactam Sodium Salt

Tazobactam Sodium Salt Structure
Tazobactam Sodium Salt structure
Common Name Tazobactam Sodium Salt
CAS Number 89785-84-2 Molecular Weight 322.27300
Density 1.92 g/cm3 Boiling Point 707.1ºC at 760 mmHg
Molecular Formula C10H11N4NaO5S Melting Point 140-147ºC
MSDS Chinese USA Flash Point 381.4ºC

Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation.

Clin. Chem. Lab Med. 53(5) , 781-91, (2015)

Recent studies have demonstrated highly variable blood concentrations of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in critically ill patients with a high incidence of sub-therapeutic levels. Consequently, therapeutic drug moni...

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.

Nucleic Acids Res. 39 , D1035-41., (2011)

DrugBank (http://www.drugbank.ca) is a richly annotated database of drug and drug target information. It contains extensive data on the nomenclature, ontology, chemistry, structure, function, action, pharmacology, pharmacokinetics, metabolism and pharmaceutic...

Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamases.

J. Antimicrob. Chemother. 51 , 605-612, (2003)

MICs of piperacillin/tazobactam are conventionally determined by varying the concentration of piperacillin in the presence of a fixed 4 mg/L tazobactam. When tested in this way, the MIC distribution for Klebsiella isolates with extended-spectrum beta-lactamas...

Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization.

Biochim. Biophys. Acta 1547 , 196, (2001)

The CMY-2 beta-lactamase, a plasmid determined class C cephalosporinase, was shown to be susceptible to inhibition by tazobactam (K(i)=40 microM). The reaction product(s) of CMY-2 beta-lactamase with the beta-lactamase inhibitor tazobactam were analyzed by el...

In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum β-lactams. . Roland, R. K., et al.

J. Infect. Dis. 4 , 226, (2000)